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Lessons in IBD pathogenesis
from new animal models of
spontaneous colitis
R BALFOUR SARTOR MD
UNTIL RECENTLY, MOST EX-perimental models of intestinal
inflammation have been induced in
laboratory animals by exposure to a
variety of toxins of questionable envir-
onmental relevance (1,2) (Table 1).
The exception is the cotton-top tamar-
in, which spontaneously develops coli-
tis and adenocarcinoma of the colon.
However, this new world marmoset is
on the endangered species list and is
not widely available. Existing animal
models have provided very important
insights into soluble mediators involv-
ed in acute and, in some cases, chronic
intestinal inflammation. However, the
acute injury response to toxins is of lim-
ited value to assist the understand-ing
of basic immunoregulatory defects
relevant to the pathogenesis of idio-
pathic chronic inflammatory bowel
disease (IBD) in humans.
Significant improvements in tradi-
tional animal models have been made
by exploring the differential genetic
susceptibility of inbred rat strains to
bacterial cell wall polymers (1,3). In-
bred Lewis rats develop a biphasic,
spontaneously relapsing granuloma-
tous enterocolitis with associated fibro-
sis, arthritis, granulomatous hepatitis,
anemia and leukocytosis after intramu-
ral injection of peptidoglycan-
polysaccharide (PG-PS) polymers. The
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chronic phase of PG-PS-induced ente-
rocolitis is T lymphocyte-mediated and
persists for at least six months. In con-
trast, Fischer F344 rats (major histo-
compatibility complex [MHC]-matched
with Lewis) and Buffalo rats develop
only transient intestinal injury and no
extraintestinal inflammation. Al-
though the PG-PS model has several
unique features, intramural injection of
PG-PS at the time of laparotomy is a te-
dious and nonphysiological means of
inducing experimental and intestinal
inflammation.
Recent advances in molecular bio-
logical techniques have made it practi-
cal to overexpress or delete genes of
interest in rodents as well as in viruses,
bacteria, yeast and cultured cells. Over-
expression (transgenic) and deletion
(knockout [KO]) of specific human leu-
kocyte antigen (HLA), cytokine and T
cell receptor (TCR) genes in rodents
have provided important and some-
times surprising models of spontaneous
colitis (Table 2). These new models, in
combination with a spontaneous mu-
tation in C3H/HeJ mice, restoration
of T cell subsets to immunocompro-
mised mice and induction of intestinal
inflammation by PG-PS, indomethacin
or trinitrobenzene-sulphonic acid in
inbred rodent strains, have provided
novel insights into mechanisms of
chronic intestinal and systemic inflam-
mation.
This paper describes clinical, histo-
logical and immunological features of
these animal models, concentrating on
the newer, genetically engineered ro-
dents that spontaneously develop
chronic intestinal inflammation.
These new rodent models provide the
tools to dissect the basic mechanisms of
chronic intestinal and systemic inflam-
mation and provide relevant insights
into the pathogenesis of IBD.
C3H/HeJ BIR SUBSTRAIN MICE
In 1994 Sundberg and colleagues
(4) described a heritable form of colitis
in mice. Over the past 10 years it be-
came apparent that individual
C3H/HeJ mice episodically developed
diarrhea and perianal ulceration with
no demonstrable pathogens. Selective
breeding of mice exhibiting diarrhea
established a pedigree in which there is
a 50% incidence of spontaneous colitis.
There is a male predominance (67%
incidence in males, 31% in females)
and seasonal variation (occurring more
often in winter than in summer). The
time course of inflammation is bipha-
sic. The most reproducible inflamma-
tion develops at three to five weeks of
age with spontaneous resolution in
most mice. Some mice exhibit chronic
inflammation, which is failure to re-
La pathogenèse des MII tirée de nouveaux modèles animaux de
colite spontanée
RÉSUMÉ : La récente multiplication de rongeurs transgéniques dont un gène ci-
blé a été éliminé (knockout [KO]) a donné lieu à un nombre de nouveaux modèles
animaux d’inflammation intestinale chronique spontanée qui donnent un
éclairage nouveau à la pathogenèse des maladies inflammatoires de l’intestin
chez l’humain (MII). La colite spontanée résultant de l’élimination de gènes re-
sponsables de l’encodage des cytokines immunorégulatrices clés (interleukine
IL-2, IL-10 et facteur de croissance transformant [TGF]-bêta) et les récepteurs des
cellules T (TCR) démontrent qu’une réponse immunitaire intacte au niveau de la
muqueuse prévient la colite. Le modèle TCR KO élimine les lymphocytes B dans
l’inflammation spontanée du côlon. Les TCR KO avec cellules B intactes provo-
quent la colite, contrairement à l’élimination simultanée des cellules T et B. Ce
modèle et l’induction de la colite chez des souris atteintes d’une immunodéfi-
cience combinée congénitale grave avec un sous-ensemble de cellules T
(CD45RHhi), qui peut être prévenue par l’ajout de la sous-série CD45RBlo, suggèrent
fortement que les sous-ensembles de cellules T régissent à la baisse l’inflamma-
tion chez l’hôte immunocompétent normal. Le rôle central des bactéries nor-
males dans l’induction et la perpétuation de l’entérocolite est rendu possible par
l’absence d’inflammation intestinale chronique chez des souris IL-2 KO non con-
taminées (stériles) et chez des rats transgéniques (HLA)-B27 soumis à l’antigène
leucocytaire humain et par l’atténuation de l’inflammation chez des souris IL-2 et
IL-10 KO dans des conditions spécifiques, sans organisme pathogène. Le rôle fon-
damental de la sensibilité génétique de l’hôte dans l’inflammation intestinale
chronique et dans les manifestations systémiques a pu être confirmé par l’installa-
tion de colite et d’inflammation périanale spontanée chez des sous-espèces de
souris Bir C3H/HeJ et des rats transgéniques HLA-B27.
TABLE 1










Carrageenan (guinea pig) Indomethacin (rat, dog)
Cotton-top tamarin
TABLE 2
New rodent models of spontaneous intestinal inflammation
Spontaneous mutation Genetically engineered Reconstituted





 TCR deleted mouse
TGF-1 deleted mouse
HLA-B272 Human leukocyte antigen B27 2 microglobulin; IL Interleukin; SCID Severe combined immuno-
deficient; TCR T cell receptor; TGF Transforming growth factor
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solve either the acute phase or sponta-
neous reactivation of chronic in-
flammation. Clinical manifesta-
tions of inflammation include occa-
sional diarrhea, hemoccult-positive
stools and perianal ulceration. Inflam-
mation is routinely found in the cecum
near the ileocecal valve, but can in-
volve the left colon. Histological char-
acteristics include focal linear ulcers
with infiltration of mononuclear cells
and neutrophils. Extraintestinal mani-
festations have not yet been reported.
The mechanism(s) of spontaneous
colitis in the C3H/HeJ Bir substrain
mouse have not yet been determined.
Presumably the propensity to develop
inflammation is the result of spontane-
ous mutation of a specific gene. At-
tempts to identify this gene are in prog-
ress, and if successful will provide
important clues to direct investigations
of specific gene mutations in IBD pa-
tients. The C3H/HeJ parent strain is
interesting because it is resistant to
bacterial lipopolysaccharide (LPS) or
endotoxin. Like the parent strain,
macrophages from C3H/HeJ Bir mice
fail to produce interleukin (IL)-1 or tu-
mour necrosis factor (TNF)-alpha in re-
sponse to in vitro LPS stimulation (5).
HLA-B27 TRANSGENIC RATS
HLA-B27/2 microglobulin (2)
transgenic rodents were developed to
determine whether experimental in
vivo expression of this class I MHC
molecule would drive a systemic in-
flammatory response that resembles
the human HLA-B27 syndrome. HLA-
B27/ 2 transgenic mice fail to exhibit
clinical evidence of spontaneous in-
flammation, but are more susceptible to
experimental infection with Yersinia
species (6). However, transgenic rats
that expressed high copy numbers of the
human HLA-B27/2 gene develop a
systemic syndrome of polyarthritis, der-
matitis, hair loss, nail changes, myocar-
ditis, epididymitis, progressive wasting,
gastritis and colitis (7). Surprisingly,
diarrhea usually precedes other mani-
festations and is clinically evident in
50% of transgenic rats by 10 weeks of
age and in almost 100% by 20 weeks of
age (8). The chronic diarrhea is not
grossly bloody and is associated with in-
termittent perianal ulceration (unpub-
lished observations). The colon is
grossly thickened and granular but has
no discrete ulceration, nodularity or
strictures. Histologically there is an in-
filtration by mononuclear cells into the
lamina propria, with occasional crypt
abscesses in severe cases. Inflammation
is confined to the mucosa in almost all
rats. Crypts are hyperplastic with reac-
tive atypia and goblet cell depletion.
The majority of rats exhibit focal areas
of gastric inflammation in the lamina
propria and submucosa with a prolifera-
tion of mucus-neck cells and grandular
ectasia. In the joints, neutrophils accu-
mulate in the joint space; the synovium
is hyperplastic, infiltrated with mono-
nuclear cells, and pannus erodes the
bone.
Several studies have been performed
to determine the mechanisms of pro-
gressive intestinal and systemic inflam-
mation in this model. The susceptibil-
ity to inflammation correlated with the
level of human HLA-B27/2 expression
on lymphoid cells (8). Eighty per cent
of hemizygous transgenic rats in two
lines that express more than 50 copies
of recombinant HLA-B27/2 per cell
developed clinically evident colitis and
systemic disease by 10 to 16 weeks of
age. Rats from lines expressing low
copy numbers of B27 failed to develop
inflammation even in the homozygous
state, whereas homozygous but not het-
erozygous offspring of mid-level line
developed clinical disease. Interest-
ingly, there is no apparent difference in
frequency or onset of colitis or systemic
inflammation in Lewis or Fischer rat
lines that express equivalent copy
numbers of the transgene. The lack of
clinically apparent spontaneous in-
flammation in transgenic mice express-
ing high copy numbers of the same con-
struct is difficult to explain.
Clinical disease can be transferred
by bone marrow cells from
HLA-B27-positive donors to irradiated
B27-negative recipients (9). Disease
can also be transferred by fetal liver
cells, but not by mature lymph node or
spleen cells, indicating that repopula-
tion of the recipient by B27-positive
progenitor cells is necessary for disease
initiation and that donor cells do not
need to be derived from rats with ac-
tive inflammation. Moreover, disease
remitted in B27-positive, irradiated re-
cipients following engraftment with
B27-negative cells. These studies dem-
onstrate the colitis is mediated by im-
munocytes and that HLA-B27
expression by nonimmune cells
(epithelial, endothelial, etc) is neither
sufficient nor necessary for colitis in-
duction.
Several studies demonstrate a fun-
damental role of ubiquitous conven-
tional flora in the pathogenesis of
HLA-B27 associated colitis and arthritis
(10,11). HLA-B27/2 transgenic rats
raised in a sterile (germ-free) environ-
ment fail to develop clinically apparent
diarrhea or arthritis and have no eleva-
tion of colonic myeloperoxidase or IL-1
compared with rats housed under con-
ventional conditions with no demon-
strable bacterial pathogens. The
incidence of arthritis in HLA-B27 trans-
genic rats repopulated with specific
pathogen-free bacterial flora is less
than in those raised in a conventional
rodent facility. Despite the absence of
colitis and arthritis, germ-free trans-
genic rats develop hair loss, dermatitis
and epididymitis to the same degree as
conventional B27-positive rats. A role
for anaerobic bacteria is suggested by
attenuation of colitis and gastritis by
metronidazole (12).
IL-2 KO MICE
IL-2 is a key immunoregulatory cyto-
kine produced by activated T helper
(TH)1 lymphocytes whose principal ac-
tivities are to stimulate proliferation
and activation of effector and regula-
tory lymphocytes (13). Mice homozy-
gous for the mutated IL-2 gene (IL-2 –/–)
develop normally for three to four
weeks before exhibiting a progressive
wasting syndrome (14). Approximately
50% of mice die by nine weeks of age
with evidence of splenomegaly, lym-
phadenopathy and severe hemolytic
anemia. Surviving mice develop
chronic diarrhea, episodic bloody
stools and rectal prolapse, which be-
come clinically evident between six
and 15 weeks of age. Progressive disease
results in death by 10 to 25 weeks.
These mice develop pancolitis, with
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the left colon affected to a greater de-
gree, but no evidence of small intesti-
nal inflammation. The inflamed colon
is thickened with crypt hyperplasia but
inflammation is confined to the mu-
cosa. The mucosa is ulcerated, crypt ab-
scesses are present and the lamina
propria is infiltrated by mononuclear
cells and neutrophils. In advanced
stages, epithelial dysplasia is noted.
Amyloidosis develops in the liver,
spleen and kidney.
Immunopathogenesis of colitis in
this model has been explored by immu-
nohistochemical staining. The number
of T and B cells within the lamina pro-
pria dramatically increases in colitic
mice which had up to 100 times more
T lymphocytes than controls. In the
late stages of disease, colonic B cells are
reduced. T lymphocytes in inflamed
colons are activated, as indicated by
the CD44 (activated memory T cells)
and CD69 (early T cell activation)
markers. T cells within inflammatory
foci have increased proliferation rates.
Lamina propria immunoglobulin (Ig)
G1 and IgA secreting cells are dramati-
cally increased and serum IgA is ele-
vated 16 to 64 times the control values.
Anticolon antibodies are increased un-
til late stages of inflammation, but are
part of a generalized autoantibody re-
sponse.
Bacterial and viral pathogens were
not detected and there was no evidence
of horizontal disease transmission in
normal litter mates. However, normal
luminal bacteria were implicated by no
clinical or histological evidence of coli-
tis in three IL-2 deficient germ-free
mice followed for five months in a ster-
ile environment. KO mice raised under
specific pathogen-free conditions de-
veloped no clinical signs of colitis, but
had evidence of mild histological and
immunological abnormalities by 17 to
20 weeks of age.
IL-10 DEFICIENT MICE
IL-10, a product of TH2 lymphocytes,
is believed to have predominantly im-
munosuppressive activity by virtue of
its ability to downregulate macrophage
natural killer cells, lymphocyte activa-
tion and cytokine production (13). IL-
10 deficient mice spontaneously de-
velop chronic inflammation of their
entire intestinal tract, with the most
severe inflammation in the duodenum,
proximal jejunum and right colon (15).
These mice develop a progressive
wasting syndrome with anemia which
begins by three to four weeks of age and
results in 30% mortality by five to six
weeks. Male and female mice are
equally affected. The proximal small
bowel is markedly thickened due to
mucosal and crypt hyperplasia. The
crypt architecture is deranged and
dysplastic with a decrease in Peyer’s
patches. Superficial erosions are
present with exudate. Away from ulcer-
ated areas the lamina propria is infil-
trated by mononuclear cells, neutro-
phils and occasional multinucleated
giant cells. Inflammation diminishes in
the distal small bowel, with atrophy of
the ileal mucosa. Colonic lesions are
predominantly atrophic. Liver histol-
ogy is normal but the bone marrow
demonstrates an increased myeloid:
erythroid ratio.
The majority of plasma cells in in-
flamed intestine produced IgA or IgG1,
and expression of MHC class II mole-
cules was increased on small intestinal
and colonic epithelial cells. Serum
IgG1 and IgA levels were increased in
IL-10 –/– mice. The antibody response
to immunization with a T cell-
dependent antigen was similar in IL-10
deleted and control mice. However, in
vivo nippostrongylus infection stimu-
lated a TH1 (increase in interferon
[IFN]-gamma) lymphokine response in
IL-10 –/– mice versus the usual TH2 (IL-4,
IL-5) response in controls. Interest-
ingly, spleen cells from the KO mice
produced 20-fold more IL-6 and TNF-
than normal mice following LPS stimu-
lation. These results suggest that defi-
cient production of IL-10, which
suppresses activation and cytokine
synthesis by macrophages, natural kil-
ler cells and T cells, could lead to
chronic stimulation by luminal bacte-
rial components. This hypothesis is
supported by the observation that IL-10
deficient mice reared under specific
pathogen-free conditions have only
isolated left-sided colitis with no histo-
logical evidence of small intestinal in-
flammation.
 TCR DEFICIENT MICE
The TCR is a heterodimer compris-
ing either  +  or  +  subunits. Anti-
gen binding to the TCR complex in
conjunction with accessory ligand
binding and costimulatory cytokines is
required for antigen-specific activation
of T lymphocytes. Mutation of various
components of the TCR has been ele-
gantly studied by Mombaerts et al (16).
Deletion of the  or  chains of the TCR
in mice induces spontaneous colitis,
with onset by three to four months of
age and mortality by six to 12 months.
Mice develop nonbloody diarrhea,
weight loss and rectal prolapse due to a
pancolitis which affects the left side
more than the right side. The colon is
quite thickened due to massive crypt
hyperplasia, goblet cell depletion,
acute and chronic inflammation of the
lamina propria and crypt abscesses.
Macroscopic mucosal ulcerations and
rectal bleeding are not seen. The small
intestine is grossly and histologically
normal, but mesenteric lymph nodes
are enlarged and focal hepatic inflam-
TABLE 3
Pathogenesis of colitis in  TCR deficient mice
Strain CD4+  T cells B cells Colitis
Wild type + + No
TCR  KO + + No
Nude – + No
RAG-1 KO – – No
TCR  KO – + Yes
TCR  KO – + Yes
TCR  KO x  KO – + Yes
Class II MHC KO – + Yes
KO Knock out; MHC Major histocompatibility complex; RAG Recombination-activating gene; TCR T
cell receptor
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matory cell infiltrates are present in
some mice.
The authors examined multiple de-
letion constructs to investigate mecha-
nisms of immunodeficiency leading to
colitis in this model (Table 3). The
common denominator in mice that
developed colitis is the absence of 
T lymphocytes and the presence of
functional B cells. An important clue is
the lack of colitis in mice with mutated
recombination-activating genes
(RAG-1) and in severe combined immu-
nodeficient (SCID) mice, which are to-
tally deficient in mature T and B
lymphocytes. These results suggest that
spontaneous colitis in this model is the
result of lack of appropriate  T cell-
mediated suppression of B cells. Analy-
sis of the  TCR mutation in several
inbred mouse strains demonstrated
that 129/Sv and C3H/He were permis-




The SCID mouse and nude rat can be
populated with immunocytes without
rejection, which permits the in vitro
study of the activity of various T cell
subpopulations. Based on studies by
Powrie and Mason (17) in nude rats,
several groups have described colitis re-
sulting from injection of T lymphocyte
subsets divided on the basis of binding
density of the monoclonal antibody
CD45RB into SCID mice (18,19).
CD45RBhi lymphocytes have been
shown to secrete profiles of TH1 lym-
phokines whereas CD45lo cells secrete
TH2 lymphokines. Injection of unfrac-
tionated cells or combined CD45RBhi
and CD45RBlo subsets caused no disease.
However, injection of only CD45RBhi
lymphocytes induced chronic wasting
beginning 10 to 30 days after reconsti-
tution with 30% mortality at 12 weeks.
Intestinal inflammation is predomi-
nantly in the colon (left side more af-
fected than right side) but was mild in
the small intestine. Histological exami-
nation of the small intestine revealed
focal mononuclear infiltrates in the
lamina propria. Colon inflammation
was characterized by focal ulceration,
chronically thickened mucosa with
crypt hyperplasia and a mononuclear
cell infiltrate of the lamina propria
with occasional neutrophils and trans-
mural inflammation. Mild periportal
infiltrates were seen in the liver.
IFN- mRNA tissue concentrations
were substantially higher than normal
values in SCID mice reconstituted with
CD45RBhi cells, but IL-10 levels were not
increased (19). IL-4 levels were unde-
tectable in all mice, and TNF- was ele-
vated in reconstituted mice with and
without colitis. These results indicate
that CD45lo lymphocytes can suppress
intestinal inflammation, which is me-
diated by the reciprocal CD45hi popula-
tion, and suggest that a disregulation
between TH1 and TH2 lymphokine pro-
duction may contribute to chronic in-
testinal inflammation. These studies
graphically illustrate the essential role
of competent immunosuppressive cells






(TGF)-beta is a macrophage product
that has pleiotropic immunological ac-
tivities including monocyte chemo-
taxis and stimulation of collagen syn-
thesis by intestinal smooth muscle
cells and fibroblasts (13). An impor-
tant immunoregulatory activity of this
molecule is suppression of lymphocyte
proliferation. TGF-1 KO mice have in-
creased in utero mortality, but appear
to develop normally until weaning
(three weeks of age), when they de-
velop a wasting syndrome and systemic
inflammation consisting of myocar-
ditis, bronchoalveolar inflammation,
pancreatitis and dermatitis (20,21).
One of the two reported TGF-1 defi-
cient lines develops diarrhea and has
incompletely described colitis (20).
The mechanisms of chronic systemic
inflammation and colitis in this model
remain obscure, but may be related to
defective suppression of lymphocytes.
Of interest, many of the organs in-





that develops in response to spontane-
ous gene mutations, targeted deletion
or overexpression of specific genes or
selective manipulation of lymphocytes
subsets can provide important insights
into the mechanisms of intestinal in-
flammation (22). Several broad immu-
nological mechanisms that mediate
spontaneous colitis are listed in Table
4. The similarities of chronic intestinal
inflammation in these models to idio-
pathic ulcerative colitis and Crohn’s
disease suggest that similar mecha-
nisms may be active in human IBD.
A theme common to many of these
models is that intestinal inflammation
develops as a result of defective immu-
nosuppression. Models of TGF-1 KO,
 TCR deletion and CD45RBhi recon-
stitution of SCID mice clearly demon-
strate the consequences of ineffective
T lymphocyte suppression and suggest
that T cell suppression is critical to nor-
mal mucosal homeostasis. The disor-
dered balance between TH1 and TH2
lymphokine profiles in IL-10 KO and
CD45RBhi  SCID mice further docu-
ments the importance of effective im-
munoregulation by lymphocytes. How
these animal studies relate to the pro-
posed TH1 profile of Crohn’s disease
and TH2 for ulcerative colitis remains
to be determined, but it is of interest
that IL-10 –/– and reconstituted SCID
mice have small intestinal inflamma-
tion and TH1 lymphokine profiles. Evi-
dence from TCR deletion studies and
IL-2 KO mice strongly suggest that in the
absence of regulatory T cells, uncon-
TABLE 4
Immunological mechanisms of spontaneous colitis in genetically engineered ro-
dents
Defective T cell suppression: CD45RB
hi
 SCID, TCR –/–, TGF-1 –/–
 TH1/TH2 lymphokines: IL-10 –/–, CD45RB
hi
 SCID
 B cell response: IL-2 –/–, TCR –/–
IL Interleukin; SCID Severe combined immunodeficient; TCR T cell receptor; TGF Transforming growth factor;
TH T helper
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trolled B lymphocyte activation is ca-
pable of mediating mucosal damage.
A second concept is that specific
gene mutations can cause spontaneous
intestinal inflammation and that clini-
cally and histologically similar lesions
can arise from different immunoregula-
tory defects. These observations illus-
trate the limited repertoire of mecha-
nisms of tissue injury, suggest that a
variety of immunoregulatory defects
may induce human IBD and imply that
there may be multiple etiologies for
these disorders. Moreover, the etiologi-
cal heterogeneity among ulcerative co-
litis and Crohn’s disease patients may
be responsible for clinical subsets of pa-
tients with predictable patterns of dis-
ease, complications and response to
medications.
A third concept is that host genetic
susceptibility determines aggressive-
ness, chronicity and complications of
intestinal inflammation. The effect of
genetic susceptibility is illustrated by
the C3H/HeJ Bir mouse and differen-
tial responses to experimental intesti-
nal inflammation in Lewis versus
Fischer rats in the PG-PS and
indomethacin models (3,23), and
C3H/ He or 129/Sv versus Balb/c mice
in the  TCR KO model (16). Identifi-
cation of genetic mechanisms of defec-
tive immunoregulation in susceptible
rodents could direct the search for ge-
netic susceptibility factors in IBD pa-
tients.
Fourth, transfer studies in HLA-
B27/2 transgenic rats demonstrate
that bone marrow-derived cells can
mediate chronic intestinal and sys-
temic inflammation. The inflamma-
tory response of these cells is geneti-
cally programmed because progenitor
cells can be derived from fetuses that do
not exhibit evidence of intestinal or
systemic inflammation. Moreover, dis-
play of HLA-B27 on host epithelial cells
is not sufficient for disease induction.
This observation suggests that in-
creased expression of MHC molecules
during experimental or idiopathic in-
flammation is a consequence of the in-
flammatory reaction and is not
necessary for chronic intestinal inflam-
mation. Resolution of spontaneous in-
testinal inflammation in HLA-B27 rats
after irradiation and successful bone
marrow engraftment from nontrans-
genic rats raise the possibility of thera-
peutic bone marrow transplantation in
IBD patients.
Finally, attenuation of spontaneous
intestinal inflammation in IL-2 and IL-
10 deficient mice raised in a pathogen-
free environment and lack of evidence
of colitis in IL-2 KO mice and HLA-
B27/2 mice living in germ-free (ster-
ile) conditions dramatically illustrate
the critical pathogenetic role of ubiqui-
tous luminal bacterial constituents.
These results parallel those observed in
indomethacin-induced enterocolitis
where gnotobiotic Lewis rats populated
with specific pathogen-free flora de-
velop chronic mid-small bowel ul-
cers but germ-free littermates have no
evidence of chronic inflammation
(24). Because microbiological condi-
tions vary between each rodent facility,
direct comparisons of the clinical fea-
tures of each spontaneous colitis model
must be made under similar conditions,
optimally using animals colonized with
the same flora. It is unknown whether
spontaneous colitis develops as the re-
sult of luminal bacteria invading tissues
of immunocompromised hosts (IL-2 and
TCR KO mice), as a hyperactive re-
sponse to bacterial components (LPS,
PG-PS) in rodents that lack effective
immunosuppressor cytokines (IL-10,
TGF- KO mice) or as an exaggerated
antibody response to ubiquitous bacte-
rial antigens (IL-2, TCR KO models and
CD45hi  SCID mice).
These genetically engineered ro-
dent models have only recently been
described so their usefulness has been
only superficially exploited. Similar
types of spontaneous intestinal inflam-
mation will almost certainly be discov-
ered as new KO and transgenic rodents
are generated to study other immuno-
regulatory molecules. Application of
sophisticated molecular and immuno-
logical techniques and further genetic
manipulation by selective crossbreed-
ing with well characterized mouse
strains should generate important in-
sights and new enthusiasm to explore
mechanisms of chronic intestinal in-
flammation.
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